Doxorubicin pathways
Institut thématique Génétique, génomique et bioinformatique · Stanford Medicine · +4 more institutions
Abstract
Thorn, Caroline F.; Oshiro, Connie; Marsh, Sharon; Hernandez-Boussard, Tina; McLeod, Howard; Klein, Teri E.; Altman, Russ B. Author Information
Citation impact
- FWCI
- 2.74
- Percentile
- 100%
- References
- 64
Authors
7- CFCaroline F. Thorn
Institut thématique Génétique, génomique et bioinformatique, Stanford Medicine, University of Alberta, University of North Carolina at Chapel Hill, Stanford University, DermSurgery Associates
- COConnie Oshiro
Stanford University, DermSurgery Associates, Institut thématique Génétique, génomique et bioinformatique, University of North Carolina at Chapel Hill, Stanford Medicine, University of Alberta
- SMSharon Marsh
Stanford Medicine, DermSurgery Associates, University of North Carolina at Chapel Hill, Stanford University, University of Alberta, Institut thématique Génétique, génomique et bioinformatique
- THTina Hernandez‐Boussard
Stanford University, University of North Carolina at Chapel Hill, University of Alberta, DermSurgery Associates, Institut thématique Génétique, génomique et bioinformatique, Stanford Medicine
- HLHoward L. McLeod
University of North Carolina at Chapel Hill, DermSurgery Associates, Institut thématique Génétique, génomique et bioinformatique, Stanford University, University of Alberta, Stanford Medicine
Topics & keywords
- Doxorubicin
- Marsh
- Philosophy
- Art
- Biology
- Medicine
- Internal medicine
- Ecology